Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats

Journal of Feline Medicine and Surgery

Volumn 4, Issue 1, 2002, Pages 13-25

  Appleton, D J ^a   Rand, J S ^a   Sunvold, G D ^b   Priest, J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b IAMS COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; CHROMIUM DERIVATIVE; CHROMIUM TRIPICOLINATE; GLUCOSE; HUMAN INSULIN; INSULIN; NEUTRAL INSULIN; PICOLINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD; BODY WEIGHT; CAT; CAT DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HALF LIFE TIME; HEREDITY; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLISM; NONHUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENESCENCE;

FELIDAE; FELIS CATUS;

ANIMALS; BLOOD GLUCOSE; CAT DISEASES; CATS; CHROMIUM; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; INSULIN; MALE; OBESITY; PICOLINIC ACIDS;

EID: 0036010731     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1053/jfms.2001.0157     Document Type: Article

References (79)

1. The short insulin tolerance test for determination of insulin sensitivity: A comparison with the euglycaemic clamp
2. Methods for assessing insulin sensitivity in man
3. Effect of chromium tripicolinate on growth, glucose tolerance, insulin sensitivity, plasma metabolites and growth hormone in pigs
4. Chromium metabolism and its role in disease processes in man
5. Chromium
6. Chromium and parenteral nutrition
7. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats
8. Urinary chromium excretion and insulinogenic properties of carbohydrates
9. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
10. Chromium intake, absorption and excretion of subjects consuming self-selected diets
11. Chromium supplementation of human subjects: Effects of glucose insulin and lipid variables
12. Effects of supplemental chromium on patients with symptoms of reactive hypoglycaemia
13. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain
14. Determination of reference values for glucose tolerance, insulin tolerance and insulin sensitivity tests in clinically normal cats
15. Toxic effects of chromium and its compounds
16. The insulin sensitivity index in nondiabetic man: Correlation between clamp-derived and IVGTT-derived values
17. The minimal modelling method. Assessment of insulin sensitivity and beta cell function in vivo
18. Quantitative estimation of Insulin Sensitivity
19. Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycaemic and hyperglycaemic glucose clamp studies
20. Effect of dietary carbohydrate source on postprandial plasma glucose and insulin concentration in cats
21. The carnivore connection: Dietary carbohydrate in the evolution of NIDDM
22. Chromium deficiency after long-term total parenteral nutrition
23. Influence of chromium picolinate on glucose usage and metabolic criteria in growing holstein calves
24. Energy Balance
25. Effect of chromium picolinate on insulin sensitivity in vivo
26. Effects of chromium supplementation on glucose tolerance in obese and nonobese cats
27. Age-related decreases in chromium levels in 55 665 hair sweat and serum samples from 40 872 patients-implications for the prevention of cardiovascular disease and type II diabetes mellitus
28. Chromium oligopeptide activates insulin receptor kinase activity
29. Application of organic bound chrome in disturbed glycoregulation therapy
30. Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity: Effect of chromium supplementation in diabetic patients
31. The effect of chromium picolinate on insulin controlled parameters in humans
32. Chromium picolinate increases membrane fluidity and rate of insulin internalization
33. Insulin sensitivity in normal and diabetic cats
34. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes
35. Chromium deficiency during total parenteral nutrition
36. Validation of the low dose insulin tolerance test for evaluation of insulin sensitivity
37. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man
38. Hormonal mechanisms in acute glucose counterregulation: The relative roles of glucagon, epinephrine, norepinephrine, growth hormone and cortisol
39. Epidemiological studies on the pathogenesis of non-insulin dependent diabetes mellitus (NIDDM)
40. Effects of chromium picolinate and exercise on the body composition of the rat
41. Effects of chromium picolinate on beginning weight training students
42. Chromium deficiency glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition
43. Role of insulin in the regulation of protein synthesis
44. The effects of chromium picolinate supplementation on body composition in different age groups
45. Effects of diets high in simple sugars on urinary chromium losses
46. Evaluation of a simplified intravenous glucose tolerance test and a reflectance glucose meter for use in cats
47. Reference values for glucose tolerance and glucose tolerance status in cats
48. The intravenous insulin tolerance test in type I diabetes
49. Comparison of five radioimmunoassay kits for the measurement of feline insulin
50. Chromium in human nutrition: A review
51. Relation of glucose tolerance factor to impaired intravenous glucose tolerance of rats on stock diets
52. Glucose-dependent uptake of chromium in human and rat insulin-sensitive tissues
53. Effects of chromium III on fasting blood glucose cholesterol and cholesterol HDL levels in diabetics
54. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
55. Effect of chromium picolinate on growth and serum and carcass traits of growing-finishing pigs
56. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986)
57. Beta-cells in type 2 diabetes mellitus
58. Glucose metabolism in glucose-intolerant older people during chromium supplementation
59. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects
60. Over-representation of Burmese in cats with diabetes mellitus in Queensland
61. Insulin resistance in non-insulin-dependent diabetes mellitus. Does it exist and can it be measured?
62. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study
63. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men
64. Mechanisms of insulin resistance in man
65. Assessment of Area
66. Extravascular dose
67. Associations between body condition and disease in cats
68. Overweight cats: Prevalence and risk factors
69. Effect of oral chromium picolinate on glycemic control in insulin-treated diabetic dogs
70. The role of chromium in mammalian nutrition
71. Influence of chromium on glucose metabolism and insulin sensitivity
72. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes
73. Evidence of a genetic basis for diabetes mellitus in Burmese cats
74. Serum cholesterol of adults supplemented with brewer's yeast or chromium chloride
75. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects
76. Nutrient composition of selected wheats and wheat products. VI. Distribution of manganese, lead, tim, cadmium, chromium, and selenium as determined by atomic absorption spectroscopy and colorimetry